Acquired Spinal Arteriovenous Fistula Presenting as Brown-Séquard Syndrome and Endovascular Treatment Outcome

2016 ◽  
Vol 96 ◽  
pp. 613.e1-613.e4 ◽  
Author(s):  
Rizvi Humaira ◽  
Chiu Yuen To ◽  
Shyam Moudgil ◽  
Richard Fessler
2005 ◽  
Vol 103 (5) ◽  
pp. 462-465 ◽  
Author(s):  
Mark J. Stephan ◽  
Gary M. Nesbit ◽  
Melinda L. Behrens ◽  
Malcolm A. Whitaker ◽  
Stanley L. Barnwell ◽  
...  

2005 ◽  
Vol 52 (2) ◽  
pp. 107
Author(s):  
Jeong Yeol Choi ◽  
Dong Hyun Kim ◽  
Hyung Woo Oh ◽  
Jeong Hwan Jang ◽  
Jae Hee Oh ◽  
...  

2020 ◽  
Vol 2020 (10) ◽  
Author(s):  
Shuhei Kawabata ◽  
Hajime Nakamura ◽  
Takeo Nishida ◽  
Masatoshi Takagaki ◽  
Nobuyuki Izutsu ◽  
...  

ABSTRACT Transarterial embolization (TAE) is a useful option for anterior cranial fossa–dural arteriovenous fistula (ACF–dAVF) as endovascular devices have progressed. Liquid agents are usually injected via a microcatheter positioned just proximal to the shunt pouch beyond the ophthalmic artery; however, high blood flow from the internal maxillary artery (IMA) often impedes penetration of embolic materials into the shunt pouch. Therefore, reducing blood flow from the IMA before embolization can increase the success rate. In the present case, to reduce blood flow from branches of the IMA, we inserted surgical gauze infiltrated with xylocaine and epinephrine into bilateral nasal cavities. Using this method, we achieved curative TAE with minimal damage to the nasal mucosa. Transnasal flow reduction is an easy, effective and minimally invasive method. This method should be considered in the endovascular treatment of ACF–dAVF, especially in patients with high blood flow from theIMA.


Head & Neck ◽  
2012 ◽  
Vol 35 (5) ◽  
pp. E138-E141 ◽  
Author(s):  
Matthew R. Sanborn ◽  
Ilya Nasrallah ◽  
David C. Stanton ◽  
Michael F. Stiefel ◽  
Robert W. Hurst ◽  
...  

Vascular ◽  
2021 ◽  
pp. 170853812110413
Author(s):  
Kenichi Honma ◽  
Terutoshi Yamaoka ◽  
Daisuke Matsuda

Objectives Intercostal artery aneurysm (IAA) is a very rare condition. Interestingly, only one study reported a case of intercostal aneurysm caused by an arteriovenous fistula (AVF). Here, we report the case of a patient with non-ruptured isolated giant true IAA caused by an AVF (size, 28 × 41 mm). Methods Treatment options for IAA include open surgery and endovascular treatment (EVT). We chose EVT, as it is minimally invasive. The right 11th intercostal artery and aneurysm diverged from the aorta. Two outflow arteries, one inflow artery, and an AVF from the aneurysm were confirmed, and coil embolization was performed. The artery of Adamkiewicz did not communicate with the right 11th intercostal artery. We performed angiography and confirmed occlusion of IAA with endoleak. Results There were no clinical findings indicative of spinal cord infarction after treatment. The patient did not develop complications and was discharged the day after treatment. Endoleak was not observed on computed tomography angiography findings at 1 month after treatment. Conclusions In our patient, an AVF might have caused IAA. Endovascular treatment for non-ruptured isolated giant IAA is a safe and minimally-invasive treatment. We found that performing EVT is beneficial when the size of the IAA exceeds 30 mm.


2010 ◽  
Vol 68 (3) ◽  
pp. 463-465 ◽  
Author(s):  
Guilherme S Nakiri ◽  
Thiago G Abud ◽  
Ricardo S Oliveira ◽  
Antonio Carlos Santos ◽  
Hélio R Machado ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document